Diabetes mellitus Posts - Page 4 of 108 on Medivizor

Evaluating the long-term effects of a moderate low-carbohydrate diet on blood glucose control and liver function in patients with type 2 diabetes

Posted by Medivizor on Sep 17, 2022 in Diabetes mellitus | 0 comments

In a nutshell This study evaluated the long-term effects of a moderate low-carbohydrate diet (LCD) on blood glucose control and liver function in patients with type 2 diabetes (T2D). The data showed that patients on a moderate LCD diet showed better blood glucose control and liver function over the long term than patients on a traditional diabetic...

Evaluating the effectiveness and safety of eplerenone treatment for patients with diabetic kidney disease.

Posted by Medivizor on Sep 11, 2022 in Diabetes mellitus | 0 comments

In a nutshell This study assessed the effectiveness and safety of eplerenone (Inspra) treatment for diabetic nephropathy (DN; diabetic kidney disease) in patients with type 2 diabetes (T2D). The data showed that eplerenone can be an effective supplement to existing clinical treatment in patients with DN. Some background DN is kidney damage...

Can teneligliptin be safely and effectively given to patients with inadequately controlled type 2 diabetes by triple oral antidiabetic drug treatment?

Posted by Medivizor on Sep 11, 2022 in Diabetes mellitus | 0 comments

In a nutshell This study compared the effectiveness and safety of teneligliptin (Tenelia) to placebo in patients with type 2 diabetes (T2D) that was inadequately controlled with triple oral antidiabetic drugs (OADs). The study showed that teneligliptin may be considered as a fourth add-on OAD treatment in these patients. Some background T2D is...

Evaluating the effectiveness, durability, and safety of faricimab in patients with diabetic macular edema.

Posted by Medivizor on Jul 16, 2022 in Diabetes mellitus | 0 comments

In a nutshell This study evaluated the effectiveness, durability, and safety of faricimab (Vabysmo) for the treatment of patients with diabetic macular edema (DME). The data showed that faricimab with extended dosing up to every 16 weeks was safe and showed good vision gains and clinical improvements in these patients. Some background...

Comparing the effects of a ketogenic diet app versus a calorie restricted, low-fat diet on weight loss in patients with overweight or obesity.

Posted by Medivizor on Jun 26, 2022 in Diabetes mellitus | 0 comments

In a nutshell This study compared the effects of a ketogenic diet mobile health application (Keyto app) with breath acetone biofeedback (device) versus a calorie-restricted, low-fat diet (WW; weight watchers) app on weight loss and metabolic risk in patients with overweight or obesity. The data showed that a ketogenic diet app with a breath acetone...

Can canagliflozin improve insulin resistance and internal fat tissue in patients with type 2 diabetes better than metformin?

Posted by Medivizor on May 31, 2022 in Diabetes mellitus | 0 comments

In a nutshell This study assessed the effects of canagliflozin (Invokana) therapy on body composition, glucose control, insulin resistance, and systemic (whole body) inflammation in patients with newly-diagnosed type 2 diabetes (T2D) compared to metformin (Glucophage). The data showed that canagliflozin therapy reduced visceral fat tissue, and...

Does diabetes affect lower urinary tract symptoms in patients with benign prostatic hyperplasia?

Posted by Medivizor on May 31, 2022 in Diabetes mellitus | 0 comments

In a nutshell This study reviewed the effect of diabetes on lower urinary tract symptoms (LUTS) in patients with benign prostatic hyperplasia (BPH). The data suggested that LUTS were increased in patients with BPH that had diabetes compared to patients without diabetes. Some background Men above 50 years of age frequently experience LUTS due to...

Can a low-carbohydrate diet affect insulin-resistant lipoprotein metabolism?

Posted by Medivizor on May 31, 2022 in Diabetes mellitus | 0 comments

In a nutshell This study determined the effect of varying carbohydrate and saturated fat dietary contents on cardiovascular disease (CVD) risk factors during weight-loss maintenance. The authors concluded that restriction of carbohydrates provided improved insulin resistance on lipoprotein metabolism, without unwanted side effects on low-density...

Can a ketogenic diet affect patients newly diagnosed with type 2 diabetes that are obese or overweight?

Posted by Medivizor on May 31, 2022 in Diabetes mellitus | 0 comments

In a nutshell This study observed the effectiveness of a ketogenic diet (KD) in patients newly diagnosed with type 2 diabetes (T2D) that were overweight or obese. The authors concluded that a DK can control body weight, blood glucose, and blood lipids (fats) in these patients but long-term adherence is a challenge. Some background...

How safe and well-tolerated is high-dose daily administration of vitamin D3 supplementation in persons with prediabetes?

Posted by Medivizor on May 31, 2022 in Diabetes mellitus | 0 comments

In a nutshell This study assessed the safety and effectiveness of oral, high-dose daily vitamin D3 for the prevention of diabetes in adults at high risk for type 2 diabetes (T2D). The authors concluded that oral, high-dose daily vitamin D3 at a dose of 4000 IU was safe and well-tolerated in patients with prediabetes that were overweight or...

Diabetes prevalence differs by race

Posted by Peigi Chace on May 25, 2022 in Diabetes mellitus |

Diabetes is complex. Many factors influence your risk of developing diabetes, including race. The way race is associated with diabetes risk may change the way physicians screen patients for the disease. Size Being overweight has been identified as a factor in diabetes, and may serve as a cue for screening. The United States Preventive Services...

Does metformin use decrease the risk of hospitalization and mortality from COVID-19?

Posted by Medivizor on May 8, 2022 in Diabetes mellitus | 0 comments

In a nutshell This study assessed the link between metformin (Glucophage) use in hospitalized and non-hospitalized patients with diabetes and different outcomes due to coronavirus disease 2019 (COVID-19). The study showed that metformin use was associated with a protective effect in COVID-19 outcomes in patients with type 2 diabetes (T2D). Some...

Diabetes mellitus Posts on Medivizor

Evaluating the long-term effects of a moderate low-carbohydrate diet on blood glucose control and liver function in patients with type 2 diabetes

Evaluating the effectiveness and safety of eplerenone treatment for patients with diabetic kidney disease.

Can teneligliptin be safely and effectively given to patients with inadequately controlled type 2 diabetes by triple oral antidiabetic drug treatment?

Evaluating the effectiveness, durability, and safety of faricimab in patients with diabetic macular edema.

Comparing the effects of a ketogenic diet app versus a calorie restricted, low-fat diet on weight loss in patients with overweight or obesity.

Can canagliflozin improve insulin resistance and internal fat tissue in patients with type 2 diabetes better than metformin?

Does diabetes affect lower urinary tract symptoms in patients with benign prostatic hyperplasia?

Can a low-carbohydrate diet affect insulin-resistant lipoprotein metabolism?

Can a ketogenic diet affect patients newly diagnosed with type 2 diabetes that are obese or overweight?

How safe and well-tolerated is high-dose daily administration of vitamin D3 supplementation in persons with prediabetes?

Diabetes prevalence differs by race

Does metformin use decrease the risk of hospitalization and mortality from COVID-19?

Categories

Recent Posts

Archives

Diabetes mellitus Posts on Medivizor

Categories

Recent Posts

Archives

Thanks for your interest in Medivizor

Invalid email